Literature DB >> 21585397

Signalling through the IL-2 receptor γ(c) peptide (CD132) is essential for the expression of immunity to Plasmodium chabaudi adami blood-stage malaria.

W P Weidanz1, G Lafleur, A Kita-Yarbro, K Nelson, J M Burns.   

Abstract

A genetic dissection approach was employed to determine whether the IL-2 receptor complex (IL-2R) comprised of α, β and γ chains is required for the suppression of Plasmodium chabaudi adami parasitemia. Blood-stage infections in IL-2Rγ(c)(-/y) mice failed to cure with parasitemia remaining elevated for > 50 days indicating the IL-2Rγ(c) through which all members of the γ(c) family of cytokines signal has an essential role in protective immunity against blood-stage malarial parasites. In contrast, the curing of parasitemia in IL-2/15Rβ⁻/⁻ mice, deficient in both IL-2 and IL-15 signalling was significantly delayed but did occur, indicating that neither cytokine plays an essential role in parasite clearance. Moreover, the observation that the time course of parasitemia in IL-15⁻/⁻ mice was nearly identical to that seen in controls suggests that the parasitemia-suppressing role of stimulating through the IL-2/15Rβ chain is owing to IL-2 signalling and not a redundant function of IL-15.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21585397      PMCID: PMC3155670          DOI: 10.1111/j.1365-3024.2011.01298.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  23 in total

1.  The influence of gammadelta T cells on the CD4+ T cell and antibody response during a primary Plasmodium chabaudi chabaudi infection in mice.

Authors:  Elsa Seixas; Luis Fonseca; Jean Langhorne
Journal:  Parasite Immunol       Date:  2002-03       Impact factor: 2.280

Review 2.  Innate immunity to malaria.

Authors:  Mary M Stevenson; Eleanor M Riley
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106

3.  Expansion of the CD4-, CD8- gamma delta T cell subset in the spleens of mice during non-lethal blood-stage malaria.

Authors:  H C van der Heyde; M M Elloso; D C Roopenian; D D Manning; W P Weidanz
Journal:  Eur J Immunol       Date:  1993-08       Impact factor: 5.532

4.  Resolution of acute malarial infections by T cell-dependent non-antibody-mediated mechanisms of immunity.

Authors:  L A Cavacini; L A Parke; W P Weidanz
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

5.  Gammadelta T cells but not NK cells are essential for cell-mediated immunity against Plasmodium chabaudi malaria.

Authors:  William P Weidanz; GayeLyn LaFleur; Andrew Brown; James M Burns; Irene Gramaglia; Henri C van der Heyde
Journal:  Infect Immun       Date:  2010-07-26       Impact factor: 3.441

6.  Immunity to Plasmodium chabaudi adami in the B-cell-deficient mouse.

Authors:  J L Grun; W P Weidanz
Journal:  Nature       Date:  1981-03-12       Impact factor: 49.962

7.  Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans.

Authors:  M Noguchi; H Yi; H M Rosenblatt; A H Filipovich; S Adelstein; W S Modi; O W McBride; W J Leonard
Journal:  Cell       Date:  1993-04-09       Impact factor: 41.582

8.  Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain.

Authors:  J P DiSanto; W Müller; D Guy-Grand; A Fischer; K Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

9.  Plasmodium chabaudi adami: interferon-gamma but not IL-2 is essential for the expression of cell-mediated immunity against blood-stage parasites in mice.

Authors:  Joan M Batchelder; James M Burns; Francine K Cigel; Heather Lieberg; Dean D Manning; Barbara J Pepper; Deborah M Yañez; Henri van der Heyde; William P Weidanz
Journal:  Exp Parasitol       Date:  2003-10       Impact factor: 2.011

10.  Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice.

Authors:  M K Kennedy; M Glaccum; S N Brown; E A Butz; J L Viney; M Embers; N Matsuki; K Charrier; L Sedger; C R Willis; K Brasel; P J Morrissey; K Stocking; J C Schuh; S Joyce; J J Peschon
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.